Fact Check Friday-“It Happened Again, It Has to Stop.”
- Network of Life
- Aug 8
- 3 min read
First, Some Good News...Bad News
Good news
We’ve reached and served record breaking numbers in 2025.
Since 2023, we have doubled the number of pregnancy test appointments we provide each month.
Our scope is widening too to fill the current void and meet the urgent need for life affirming maternal healthcare. We’ve expanded our succession of medical interventions, called the Wellness Journey. These sessions for both moms and dads include Early Pregnancy Assessment, Birth Mapping, Early Infant Care, Childbirth Class, 4th Trimester Visits for post partum screening, and more. Because of the growth in our Wellness programming, in May alone we served women and men at 200 separate appointments—the highest ever in our 40 year history.
Bad news
Our outcomes are rising faster than our fundraising.
Our need is urgent. We are experiencing a $47,000 short fall for this summer.
We can only expect higher numbers of clients this fall. The abortion landscaping is going through a major shift and we are seeing the impact at our doors.
As our program numbers and costs increase, I am asking you to consider how you might increase your giving today and prayerfully consider additional giving before the end of the year. Every gift helps.
It happened again. And it has to stop.
These stories are becoming routine. And all are preventable. As the abortion industry claws for more money, more power, and more death, the impact on women and families is measurable and growing.
The Ethics in Public Policy Center released the following bombshell findings in May of this year that confirm what we are seeing in our centers.
10.93 percent of women experience sepsis, infection, hemorrhaging, or another serious adverse event within 45 days following a mifepristone abortion. The rate of serious adverse events following mifepristone abortions is at least 22 times as high as the summary figure of “less than 0.5 percent” in clinical trials reported on the drug label.
The real-world failure rate of mifepristone abortion—at least 5.26 percent, or about one in 19 cases—is double the failure rate from the U.S. clinical trials and roughly two-thirds higher than the combined failure rate from all clinical trials reported on the FDA-approved drug label.
Adjusting to avoid double-counting, the study found that 13.51 percent of women—roughly one in seven—experience at least one serious adverse event or repeated abortion attempt within 45 days of first attempting a mifepristone abortion.
This largest-known study of the abortion pill is based on analysis of data from an all-payer insurance claims database that includes 865,727 prescribed mifepristone abortions from 2017 to 2023.
This is Preventable
We must reach women first. We can prevent these tragic stories by reaching those seeking abortion online. And we can care for those we may not reach in time.
Our services empower women and men to choose life! Our 2025 numbers are higher than ever before. But we need your partnership now.
Please consider a generous gift to help us save more lives and transform families.
Take it to Prayer
Pray for our city and for the vulnerable neighbors we serve.
Pray for those seeking abortion online to find our advertising and turn to us first.
Pray for those who have begun the abortion pill protocol to find us and find help.
Pray for our church congregations to discover new ways to serve, provide resources and care for young families in Pittsburgh.
Pray that the love of Christ will be a light to our city and that our good work would bear fruit in the lives of our client families.
Pray that Pittsburgh could become a sanctuary city for life!
Comentarios